Abhinav Deol

16PUBLICATIONS
92CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Transplantation immunologyCardiology (incl. cardiovascular diseases)Regenerative medicine (incl. stem cells)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 28, 2026
Lisocabtagene maraleucel combined with ibrutinib in R/R CLL or SLL: primary results from TRANSCEND CLL 004.

|Jun 03, 2025
Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma.

Sundar Jagannath, Thomas G Martin, Yi Lin

|Aug 02, 2024
Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.

Michael D Jain, Jay Y Spiegel, Loretta J Nastoupil

|May 22, 2024
Haploidentical vs. mismatched unrelated donor transplants with posttransplant cyclophosphamide-based GVHD prophylaxis.

Dipenkumar Modi, Seongho Kim, Maya Shatta

|Jan 04, 2024
Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids.

Olalekan O Oluwole, Edouard Forcade, Javier Muñoz

|Dec 05, 2023
Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium.

Michael D Jain, Miriam T Jacobs, Feng Gao

Pageof 3

Frequent Collaborators

5 joint publications

Julie M Vose

5 joint publications

Olalekan Oluwole

5 joint publications

Yi Lin

4 joint publications

Sattva S Neelapu